AIDS/syringe exchange study

November 06, 2002

(SACRAMENTO, Calif.) -- Drug users with access to controversial syringe-exchange programs are up to six times less likely to put themselves at risk of HIV infection, according to a new UC Davis study published in the November issue of Journal of Acquired Immune Deficiency Syndromes.

"While programs to control the spread of HIV by providing clean needles to drug users remain controversial in California and around the country, this study clearly shows that syringe-exchange programs save lives -- and save society millions of dollars in health care costs required to treat HIV patients," said lead author David R. Gibson, associate professor of infectious and immunologic diseases at UC Davis and a senior scientist at UC San Francisco's Center for AIDS Prevention Studies.

Injection drug use is linked to about one-third of all HIV/AIDS cases, according to the Centers for Disease Control and Prevention. Drug users contract these diseases by sharing contaminated syringes. To curb this high-risk behavior, syringe exchanges operate in a variety of settings, including storefronts, vans, sidewalk tables, health clinics, and places where drug users gather.

The first organized syringe-exchange programs in the United States were established in the late 1980s, despite strong opposition from some communities on moral grounds -- opposition that continues today.

"While this study should open the way to a more fact-based discussion of these controversial programs, a small, vocal minority simply refuses to look at the scientific evidence -- they are essentially 'data-proof,'" Gibson said.

The UC Davis study offers the most detailed examination to date of the complex factors of the role of syringe exchanges in reducing HIV risk behavior, Gibson said. The study addressed several key challenges that have tended to distort the findings of previous syringe-exchange studies, he added.

For instance, the study did a better job than previous studies had done in correcting for pre-existing differences between injecting drug users who seek to use a syringe-exchange program compared with those that do not. In addition, the study controlled for other sources of syringes that drug users may have and compared drug users who had other sources of syringes with those without other sources.

To adjust for these factors, the UC Davis researchers adopted more rigorous statistical controls than previous studies.

Among injecting drug users who already have some access to clean syringes, a syringe-exchange program results in a two-fold reduction in HIV risk behavior, said Gibson. For drug users with no other easy access to clean syringes, the benefits are even more significant -- a six-fold reduction in risk behaviors. Syringe-exchange programs will naturally appear less effective in communities with multiple sources of clean syringes compared to programs that constitute a community's only supply.

"These findings underscore just how critical syringe exchange may be for all injecting drug users, but especially those who lack the resources or contacts to obtain syringes in other ways," said Gibson. "It also suggests syringe-exchange programs can be most effective in reducing HIV by focusing on getting sterile syringes to these most vulnerable drug users."

The findings are especially relevant in California in the wake of an intense debate over Senate Bill 1785, which would have allowed pharmacies to sell syringes to adults without a prescription. Gov. Gray Davis vetoed the bill in late September because it did not require a one-to-one needle exchange. Without this provision, Gov. Davis said, the bill could increase the number of contaminated needles and syringes in parks, beaches, and other public areas.

"Without access to clean syringes through pharmacies, injecting drug users must continue to rely on exchange programs to avoid high-risk behavior and curb the spread of HIV," said Gibson.

The study followed a group of 259 untreated injecting drug users in the San Jose area. Each of the participants was interviewed at the beginning of the study and then participated in follow-up interviews -- an average of about 11 months later. Some of the participants were clients of the San Jose syringe exchange, which used a mobile van to visit five sites frequented by injecting drug users.

The new study builds on a July 2001 UC Davis study, also lead by Gibson, which reviewed 42 studies on syringe-exchange programs from the United States, Canada, the United Kingdom and the Netherlands. The study concluded that previous studies often underestimated the effectiveness of syringe-exchange programs in communities where clean needles can be easily obtained from sources other than the syringe exchange. In addition, researchers have found that in areas where drug users have a choice between syringe exchange and legally obtaining syringes from pharmacies, the higher-risk users tend to gravitate to syringe-exchange programs. As a result, the syringe exchanges appear less effective when users of syringe exchange are compared with nonusers.

The first organized syringe-exchange programs in the United States were established in Tacoma, Washington; Portland, Oregon; San Francisco; and New York City. By 1997, there were 113 programs in more than 30 states, the District of Columbia, and Puerto Rico, which exchanged more than 17 million syringes, according to the Centers for Disease Control and Prevention.
-end-
Research was funded with a grant from the National Institute on Drug Abuse, United States Public Health Service.

University of California - Davis Health System

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.